These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 511336)

  • 21. The penicillins.
    Wright AJ
    Mayo Clin Proc; 1999 Mar; 74(3):290-307. PubMed ID: 10090000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
    Perea EJ; Nogales MC; Aznar J; Martin E; Iglesias MC
    J Antimicrob Chemother; 1980 Jul; 6(4):471-7. PubMed ID: 6253432
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro and in vivo action of mezlocillin and azlocillin combined with sisomicin.
    Dzierzanowska D; Jeljaszewicz J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):346-55. PubMed ID: 6417945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mechanisms of azlocillin resistance in Pseudomonas aeruginosa].
    Labia R; Morand A; Ben Yaghlane H
    Presse Med; 1984 Mar; 13(13):777-9. PubMed ID: 6231594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experiences using acylureido-penicillins (azlocillin, mezlocillin) in pediatrics].
    Weingärtner L; Sitka U; Patsch R; Thiemann HH
    Klin Padiatr; 1984; 196(1):28-35. PubMed ID: 6694339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetic studies on broad spectrum antibiotic combinations of penicillin and oxacillin in normal volunteers (author's transl)].
    Adam D; Bauer W; Seitz B; Voigt I
    Arzneimittelforschung; 1979; 29(11):1769-804. PubMed ID: 543889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacological studies of carbenicillin.
    Bodey GP; Rodriguez V; Stewart D
    Am J Med Sci; 1969 Mar; 257(3):185-90. PubMed ID: 4975629
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
    Møller NE; Eriksen KR; Feddersen C; Flensborg EW; Høiby N; Norn S; Rosendal K; Schiøtz PO; Skov PS
    Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbenicillin: a new semisynthetic penicillin active against Pseudomonas pyocyanea.
    Knudsen ET; Rolinson GN; Sutherland R
    Br Med J; 1967 Jul; 3(5557):75-8. PubMed ID: 4961466
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antibacterial activity of mezlocillin and azlocillin/A survey (author's transl)].
    Knothe H
    Arzneimittelforschung; 1979; 29(12a):1916-20. PubMed ID: 120745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro inactivation of gentamicin, tobramycin, and netilmicin by carbenicillin, azlocillin, or mezlocillin.
    Henderson JL; Polk RE; Kline BJ
    Am J Hosp Pharm; 1981 Aug; 38(8):1167-70. PubMed ID: 6455916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative activity of cefsulodin on Pseudomonas aeruginosa, Acinetobacter and Enterobacteriaceae (author's transl)].
    Courtieu AL; Drugeon HB; Bryskier A; Chung SS; Reynaud A
    Pathol Biol (Paris); 1982 Jun; 30(6):432-9. PubMed ID: 6810287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urine concentrations of five penicillins following oral administration to normal adult dogs.
    Ling GV; Conzelman GM; Franti CE; Ruby AL
    Am J Vet Res; 1980 Jul; 41(7):1123-5. PubMed ID: 6776855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro examination of some new penicillin derivatives with activity against Pseudomonas aeruginosa: azlocillin, mezlocillin and piperacillin compared with carbenicillin].
    Høiby N; Bremmelgaard A; Schouenborg P
    Ugeskr Laeger; 1979 Oct; 141(41):2815-8. PubMed ID: 120049
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative activity and beta-lactamase stability of carbenicillin, ticarcillin, azlocillin, mezlocillin and cefotaxime.
    Tselentis J; Cordossis T; Kosmidis J; Lambropoulos S; Melissinos K
    J Antimicrob Chemother; 1981 Oct; 8(4):317-21. PubMed ID: 6271725
    [No Abstract]   [Full Text] [Related]  

  • 36. Agar (disk) diffusion test susceptibility of clinical isolates of Pseudomonas aeruginosa to azlocillin, cefotaxime, cefsulodin, lamoxactam, mezlocillin, and piperacillin.
    Traub WH
    Chemotherapy; 1982; 28(4):257-60. PubMed ID: 6288329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetic studies and their value for a better dosage schedule of antibiotics. I. The penicillins.
    Van Saanen P
    Rev Roum Med Intern; 1973; 10(2):149-57. PubMed ID: 4697586
    [No Abstract]   [Full Text] [Related]  

  • 38. BRL 20330, an oral prodrug of temocillin: bioavailability studies in man.
    Basker MJ; Merrikin DJ; Ponsford RJ; Slocombe B; Tasker TC
    J Antimicrob Chemother; 1986 Sep; 18(3):399-405. PubMed ID: 3095301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of intravenous mezlocillin in chronic hemodialysis patients.
    Francke E; Mehta S; Neu HC; Appel GB
    Clin Pharmacol Ther; 1979 Aug; 26(2):228-31. PubMed ID: 455891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic studies with mecillinam and pivmecillinam.
    Roholt K; Nielsen B; Kristensen
    Chemotherapy; 1975; 21(3-4):146-66. PubMed ID: 1157572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.